Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Alrite

Research Leaders

7 sponsors active, led by Thrasher Research Fund

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07369817Not ApplicableNot Yet Recruiting

Optimization and Testing of ALRITE, a Clinical Decision Support Tool for Management of Respiratory Illnesses in Young Children in Primary Care Health Facilities in Uganda

NCT00786877Phase 3CompletedPrimary

Cookstove Replacement for Prevention of ALRI and Low Birthweight in Nepal

Showing all 2 trials

Research Network

Common Treatments

  • Alrite1
  • Improved Biomass Cookstove With Exterior Ventilation1
  • Phase 2 Intervention Arm Lpg Stove1

Active Sponsors

  • Thrasher Research Fund1
  • National Institute of Environmental Health Sciences (NIEHS)1
  • Tribhuvan University, Nepal1
  • National Heart, Lung, and Blood Institute (NHLBI)1
  • University of Washington1

Top Investigators

Related Conditions

  • Pneumonia Childhood1
  • Childhood Asthma1
  • Wheezing Lower Respiratory Illness1

Activity Timeline